Scott Solomon
Nov 4, 2022
DELIVER presentations at AHA
The DELIVER team was proud to present 6 new papers at the American Heart Association scientific sessions in Chicago this week. The following analyses were presented:
First and Repeat Episodes of Worsening Heart Failure in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction: An Analysis of DELIVER presented by Pardeep Jhund
Influence of dapagliflozin on quality of life in patients with heart failure with mildly reduced or preserved ejection fraction presented by Mikhail Kosiborod
Sex Differences in Characteristics, Outcomes and Treatment Response with Dapagliflozin across the Range of Ejection Fraction in Patients with Heart Failure presented by Wendy Wang
Dapagliflozin in Black and White Patients With Heart Failure presented by Jawad Butt
Impact of Coronavirus Disease-2019 in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction presented by Ankeet Bhatt
Dapagliflozin in patients with HFmrEF/HFpEF treated with an MRA or sacubitril/valsartan presented by Mingming Yang